FCA Pricing Practices

An update on our approach and actions

Many of you will now be aware of the FCA Pricing Practices legislation affecting both consumer and business insurance products. While the legislation affects PMI less than other general insurance products, we want to update you on the steps we're taking to meet the requirements.

What's the Pricing Practices review?                     

The FCA concluded a review of general insurance pricing practices in September 2020. It has now introduced a set of new regulations to make sure firms offer products and services that deliver fair value to consumers.

Here are the main points you need to know:

  • There are additional product governance requirements from 1 October 2021
  • The other two requirements – providing customers with ways to opt out of Autorenewal and the pricing remedy - don’t apply to private medical insurance

Our approach and action relating to the product governance rules

We have well-established product oversight and governance controls in place to make sure we manage activities throughout the lifecycle of a product to an acceptable standard.

  • For customers - we want our general insurance products to provide fair value, where customers can buy them for a fair price and use them as they would reasonably expect
  • For businesses – we uphold the high reputational and conduct risk management expectations of today’s insurance firms, following legal and regulatory requirements and managing operational risks to industry standards

We’ve already made the necessary changes to our process for additional product governance requirements. You can find our revised product approval process on our website.

You’ll find our target market statements for all open products under the ‘Helping you sell’ section of our Aviva Adviser site. For example, for Healthier Solutions, you’ll find all target market statements (including those for closed products) under each product in the ‘Other documents’ section of the Document Library. Simply type in ‘target market statement’.

We'll keep you updated and share any guidance that will help you meet requirements. In the meantime, if you have any questions, please contact your Aviva Sales Manager

Our response to the pricing remedy

The new rules for home and motor products come into force on 1 January 2022. This means pricing for existing customers should be no higher than the equivalent price for new customers.

We’ve been asked if we’ll be adopting a similar policy for health insurance pricing. At the moment, the pricing remedy rules don’t apply to health or PMI products. As you’d expect, we aim to price our health products fairly, but pricing for health products is different to pricing for home and motor insurance.

For health products, we normally underwrite customers only once at the start of their policy. Generally, the more recently a customer was underwritten the less likely they are to claim. Plus, some customers may have long-running conditions – such as cancer – where we may fund treatment for many years. Because of this, we think it’s reasonable to reflect this in the price we charge. This means premiums may go up at renewal.

That’s why we believe it would be inappropriate to adopt the same approach as for home and motor insurance. However, you can be sure we’ll take every care to make sure both new and existing customers receive good value.